LatchBio

"Kyle Giffin and Kenny Workman are two of the most special human beings I know. The way the three of us worked together—iterating on ideas, disagreeing, agreeing on fundamental values, and debating passionately—helped us arrive at higher truths." 🚀💡 In Part 3 of my conversation with Alfredo Andere 🦖, Co-Founder & CEO of LatchBio on The Biotech Startups Podcast, we dive deep into the power of collaboration and the journey of building a revolutionary biotech startup. Below are some highlights from our conversation: – 🤝 The importance of finding the right co-founders and building a strong team dynamic – 🧬 The genesis of LatchBio and identifying the need for better data infrastructure in biotech – 💻 Transitioning from academia to entrepreneurship and the challenges faced along the way – 🌐 The vision of creating a cloud computing platform specifically tailored for biotech companies – 🔬 How LatchBio is accelerating research by bridging the gap between wet lab scientists and computational biologists Alfredo's insights on teamwork, innovation, and the future of biotech are seriously inspiring. This episode is jam packed with valuable lessons for aspiring entrepreneurs and biotech professionals alike! Apple Podcasts & Spotify links in the comments below! 👇🏽 #biotechnology #lifesciences #podcast

I'll be attending NextGen Omics 2025 in Boston today and tomorrow with Kyle Giffin and Kassem Ezzeddine. We're excited to connect with folks working on the frontier of single-cell, spatial, or other innovative solutions in omics. If you're planning to be there, lmk, we'd love to meet up and chat. Looking forward to some great conversations!

Our CEO, Ken Wang, takes the stage at Nvidia’s GTC conference, sharing how our advanced computational pipelines are shaping the future of spatial epigenomics. Stay tuned for more innovative breakthroughs! #GTC #nvidia #epigenetics

LatchBio is sponsoring #NextGenOmics 2025. We'll be giving a presentation on how to quickly set up your own cloud-based multi-omics software platform. Come find our team in-person!

We're heading to Vegas! 🎲 Looking to empower your core customers with flexible, scalable, and streamlined data analysis? Come find our team at ABRF 2025.

We're heading to Vegas! 🎲 Looking to empower your core customers with flexible, scalable, and streamlined data analysis? Come find our team at ABRF 2025.

Spatial biology has been exploding—and keeping track of the key players and technologies gets complicated. To simplify things, we're presenting a comprehensive mapping of the 20 companies and 42 products defining spatial biology today. We’ve categorized each product by Imaging or Sequencing based, tissue types, species, and analyte. You can learn more about each technology and mix and match filters at latch (dot) bio (/) spatial-landscape. Lastly, we are also kicking off a series exploring different branches of spatial tech, starting with a deep dive into sequencing-based transcription. And when I say “we” I mostly mean Hannah Le — our incredible Head of Product ! As this is meant to be a living resource for the biotech community, please contact us with any feedback and updates to keep this resource accurate and up-to-date.

Have you heard? Curio has a new Bioinformatics Portal for cloud-based data processing! Don’t miss our virtual information webinar to learn about: ➡️ How to efficiently process your Curio Trekker and Seeker datasets ➡️ How to visualize and explore spatial transcriptomics results Register here: https://hubs.ly/Q032yVwH0

What happens when single-cell sequencing becomes cheaper, faster to process and easier? More scientists can access it, existing applications become more powerful and new types of experiments become possible. While one of the most exciting technologies of the past decade, single-cell has been largely relegated to those with larger budgets and extensive lab expertise. Existing technologies require additional equipment, expensive reagent costs or suffer from multiple days of tedious lab workflows. The consequence? Many labs and companies still don’t use single-cell sequencing even though their research would greatly benefit. The ones that do have yet to adopt it for large scale perturbation studies, drug screens or population-scale variation studies useful for engineering molecules, developing drugs or understanding patient populations. Here we explore a new technology developed by CS Genetics that allows scientists to index and prep cells entirely in-solution, using standard plastic labware, with 4.5 hours of hands-on time. In a blog post, we explore: - The technology - The data - What’s now possible - How accessible analysis integrates with SimpleCell Packaging single-cell into budget-friendly, easy-to-use kits has exciting implications for new types of experiments. Immediately, the familiar class of data-rich atlasing studies become accessible to labs and fledgling biotechs across the world. Why do certain T-cells stick around in joint tissue and display autoimmune behavior in rheumatoid arthritis? Why do certain patients respond to immunotherapy in hepatocellular carcinoma and others do not? More studies, more data, more compounding knowledge.

Curio Trekker and Curio Seeker kits represent some of the most advanced spatial omics technologies out there. We've been following their work for years. Now, Curio Biosciences just announced their new Bioinformatics Portal, powered by LatchBio! This is a huge milestone, months (years?) in the making, and we are looking forward to collaborate with them in helping researchers process and visualize large-scale spatial data more efficiently, ultimately making it faster and easier to draw meaningful conclusions. Curio and Latch will be sharing how these solutions work in practice during an upcoming webinar. If you’re interested in the possibilities of spatial omics and want a concrete example of how these tools can streamline your process, join below.